Evidence map›Paper›PMID 36300096›Full record

ArticleFrontiers in oncology2022

MBTPS1 regulates proliferation of colorectal cancer primarily through its action on sterol regulatory element-binding proteins.

Liat H Hartal-Benishay, Esraa Saadi, Shir Toubiana, Lior Shaked, Maya Lalzar, Ossama Abu Hatoum, Sharon Tal, Sara Selig, Liza Barki-Harrington

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Liat H Hartal-BenishayDepartment of Human Biology, Faculty of Natural Sciences, University of Haifa, Haifa, Israel.
Esraa SaadiDepartment of Human Biology, Faculty of Natural Sciences, University of Haifa, Haifa, Israel.
Shir ToubianaDepartment of Genetics and Developmental Biology, Rappaport Faculty of Medicine and Research Institute, Technion, Haifa, Israel.
Lior ShakedDepartment of Human Biology, Faculty of Natural Sciences, University of Haifa, Haifa, Israel.
Maya LalzarBioinformatics Service Unit, Faculty of Natural Sciences, University of Haifa, Haifa, Israel.
Ossama Abu HatoumDepartment of Surgery, Ha'emek Medical Center, Afula, Israel.
Sharon TalDepartment of Human Biology, Faculty of Natural Sciences, University of Haifa, Haifa, Israel.
Sara SeligDepartment of Genetics and Developmental Biology, Rappaport Faculty of Medicine and Research Institute, Technion, Haifa, Israel.
Liza Barki-HarringtonDepartment of Human Biology, Faculty of Natural Sciences, University of Haifa, Haifa, Israel.
University of Haifa · ILRappaport Family Institute for Research in the Medical Sciences · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Among the main metabolic pathways implicated in cancer cell proliferation are those of cholesterol and fatty acid synthesis, both of which are tightly regulated by sterol regulatory element-binding proteins (SREBPs). SREBPs are activated through specific cleavage by membrane-bound transcription factor protease 1 (MBTPS1), a serine protease that cleaves additional substrates (ATF6, BDNF, CREBs and somatostatin), some of which are also implicated in cell proliferation. The goal of this study was to determine whether MBTPS1 may serve as a master regulator in proliferation of colorectal cancer (CRC). Tumors from CRC patients showed variable levels of MBTPS1 mRNA, which were in positive correlation with the levels of SREBPs and ATF6, and in reverse correlation with BDNF levels. Chemical inhibition of MBTPS1 activity in two CRC-derived cell lines resulted in a marked decrease in the levels of SREBPs, but not of its other substrates and a marked decrease in cell proliferation, which suggested that MBTPS1 activity is critical for proliferation of these cells. In accordance, CRISPR/Cas9 targeted knockout (KO) of the

Indexed as

colon cancerCRISPR/Cas9HT-29lipid metabolismMBTPS1site-1 proteaseSKI-1/S1PSREBP

Identifiers

PMID36300096
PMCPMC9592115
OpenAlexW4304014019

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.